Indapamide and Xifaxan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Indapamide (indapamide) and Xifaxan (rifaximin). Common drug interactions include disease recurrence among females and gastrointestinal haemorrhage among males.

The phase IV clinical study analyzes what interactions people have when they take Indapamide and Xifaxan. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,152 Indapamide users. Check the latest studies of Indapamide.

What is Xifaxan?

Xifaxan has active ingredients of rifaximin. It is often used in irritable bowel syndrome. eHealthMe is studying from 16,609 Xifaxan users. Check the latest studies of Xifaxan.



On Jul, 05, 2026

11 people who take Indapamide and Xifaxan together, and have interactions are studied.

Indapamide and Xifaxan drug interactions.

What are the common drug interactions of Indapamide and Xifaxan, by gender? *:

female:

  1. Disease recurrence
  2. Facial bones fracture (bone fracture of face)
  3. Fall
  4. Renal disorder (kidney disease)

male:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Decreased appetite
  4. Headache (pain in head)
  5. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  6. Vision blurred

What are the common drug interactions of Indapamide and Xifaxan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Facial bones fracture (bone fracture of face)
  2. Fall

50-59:

n/a

60+:

  1. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Renal disorder (kidney disease)

What are the existing conditions these people have? *

  1. Pulmonary Embolism (blockage of the main artery of the lung): 5 people, 45.45%
  2. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 5 people, 45.45%
  3. Renal Cell Carcinoma (a kidney cancer): 3 people, 27.27%
  4. Thyroid Diseases: 2 people, 18.18%
  5. Stress And Anxiety: 2 people, 18.18%
  6. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 2 people, 18.18%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
  8. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 9.09%
  9. Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 9.09%
  10. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and Xifaxan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Indapamide and Xifaxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xifaxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Indapamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xifaxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on indapamide and rifaximin (the active ingredients of Indapamide and Xifaxan, respectively), and Indapamide and Xifaxan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: